Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06011759 · ClinicalTrials.gov registry record · NA

Maintaining Implementation Through Dynamic Adaptations (MIDAS) Suicide Prevention 2.0 Clinical Telehealth

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
4
Enrollment target

NCT06011759: Completed NA study, sponsored by VA Office of Research and Development.

NCT06011759 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06011759, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

Scientific advances are constantly leading to better treatments. However, it is quite challenging for healthcare systems, including VA, to ask very busy providers to change the way they practice. The MIDAS QUERI program helps providers improve the way they treat VA patients. This project will focus on increasing referrals to the Suicide Prevention 2.0 Clinical Telehealth (SP 2.0) initiative through the delivery of Academic Detailing and LEAP (a team-based quality improvement program). SP 2.0 provides accessible, evidence-based suicide prevention treatment to all Veterans with a history of suicidal self-directed violence or preparatory behaviors in the past 12 months.

Primary Outcome

The quarterly SP2Clin metric data is reported and available on a VA national dashboard. The SP2Clin metric is calculated by the number of suicide prevention telehealth consults submitted among those with a suicide behavior event.

Interventions

  • BEHAVIORAL Academic Detailing (AD)
  • BEHAVIORAL LEAP

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2022-11-01
Est. Completion 2024-08-29
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT06011759 record still lists

NCT06011759 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Academic Detailing (AD) is the first listed.

NCT06011759 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06011759 about?

NCT06011759 is a clinical study titled "Maintaining Implementation Through Dynamic Adaptations (MIDAS) Suicide Prevention 2.0 Clinical Telehealth". Scientific advances are constantly leading to better treatments. However, it is quite challenging for healthcare systems, including VA, to ask very busy providers to change the way they practice. The MIDAS QUERI program helps providers improve the way they treat VA patients. This project will focus ...

What is the current status of trial NCT06011759?

This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2022-11-01. Estimated completion is 2024-08-29.

What interventions are being tested in trial NCT06011759?

The interventions under investigation include: Academic Detailing (AD) (BEHAVIORAL), LEAP (BEHAVIORAL).

Who is sponsoring clinical trial NCT06011759?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06011759's enrollment target sits among peer trials

4 1996th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06011759, the US trial registry maintained by the National Library of Medicine. NCT06011759 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.